Asia-Pacific region is expected to exhibit fastest YoY growth owing to improving infrastructure in the healthcare
industry and rising demand for efficient procedures in developing economies such as China and India. As per
the estimation made by WHO, number of deaths caused by cancer in Asia is estimated to reach up to 6.4 million.
Competitive Insights
Contributing companies towards developing the biopsy devices include DTR Medical Hologic, Inc., INRAD, Inc.,
Devicor Medical Products Inc. and Angiotech. These companies are engaged in producing breakthrough
technologies in order to gain significant share in the sector.
Market Segment:
Biopsy Devices Product Outlook
• Needle-based Biopsy Guns
• Vacuum-assisted Biopsy (VAB) Devices
• Fine Needle Aspiration Biopsy (FNAB) Devices
• Core Needle Biopsy (CNB) devices
• Biopsy Guidance Systems
• Manual
• Robotic
• Biopsy Needles
• Disposable
• Reusable
• Biopsy Forceps
• General Biopsy Forceps
• Hot Biopsy Forceps
• Others
• Brushes
• Curettes
• Punches
Biopsy Devices Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW